Tranylcypromine is classified as Antidepressant (irreversible, nonselective monoamine oxidase inhibitor: MAO-A > MAO-B). It belongs to the Phenethylamine (substituted amphetamine; cyclopropylamine) chemical class.
Tranylcypromine molecular structure diagram from the DrugsPRO substance library.
Also known as: Parnate, SKF-385
Classification
Chemical: Medicine
Chemical: Phenethylamine
Psychoactive: Depressant
Effects
Stimulation
Physical Energy
Insomnia
Headache
Loss Of Appetite
Sedation
Euphoria
Anxiety
Agitation
Dizziness
Motivation Enhancement
Reduced Anxiety
Dulled Perception
Light Sensitivity
Appetite Suppression
Dehydration
Increased Libido
Disinhibition
Routes of Administration
Oral
Dosage
Heavy: >60 mg/day (not recommended; exceeds typical max of 60 mg/day)
Light: 10–20 mg/day
Common: 30–40 mg/day (divided)
Strong: 50–60 mg/day (divided)
Threshold: 10 mg/day
Duration
Onset: 1-3 h
Peak: 0 h
Offset: 4-8.4 h
After Effects: 4-8.4 h
Total Duration: 4-8.4 h
Harm Reduction
Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.
Sources
Substance data is aggregated from the following public harm-reduction and reference sources.
This static page is intended as a readable non-JS and prerender-friendly library export.
Get the full DrugsPRO experience
Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.
Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu
Tranylcypromine - Treoir substaint DrugsPRO
Tranylcypromine: Tranylcypromine is classified as Antidepressant (irreversible, nonselective monoamine oxidase inhibitor: MAO-A > MAO-B). It belongs to the Phenethylamine (substituted amphetamine; cyclopropylamine) chemical class.